|
Home | Medical-Newswire.Com:
|
 (Medical-NewsWire.com, September 04, 2017 ) Report, "Metastatic Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A...
Source: EmailWire.com
 (Medical-NewsWire.com, September 04, 2017 ) " Francisella Tularensis Infections-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Francisella Tularensis Infections. The Report covers the product profiles in various stages...
Source: EmailWire.com
 (Medical-NewsWire.com, September 04, 2017 ) Publisher's, "Receptor For Advanced Glycation End Product (RAGE) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Receptor For Advanced Glycation End Product (RAGE)...
Source: EmailWire.com
 (Medical-NewsWire.com, September 04, 2017 ) Report, "Acute Renal Failure (ARF) (Acute Kidney Injury)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross...
Source: EmailWire.com
 (Medical-NewsWire.com, September 04, 2017 ) " Bladder Pain-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Bladder Pain. The Report covers the product profiles in various stages of development including Discovery, Pre-clinical,...
Source: EmailWire.com
 (Medical-NewsWire.com, September 04, 2017 ) "Kv1.3 Potassium Channel Blockers-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Kv1.3 Potassium Channel Blockers. The Report covers the product profiles in various stages of...
Source: EmailWire.com
 (Medical-NewsWire.com, September 04, 2017 ) "Hedgehog Signaling Pathway Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Hedgehog Signaling Pathway Antagonists. The Report covers the product profiles in various...
Source: EmailWire.com
 (Medical-NewsWire.com, September 04, 2017 ) " Spinal Stenosis-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Spinal Stenosis. The Report covers the product profiles in various stages of development including Discovery,...
Source: EmailWire.com
 (Medical-NewsWire.com, September 04, 2017 ) "Caspases Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Caspases Inhibitors. The Report covers the product profiles in various stages of development including Discovery,...
Source: EmailWire.com
 (Medical-NewsWire.com, September 04, 2017 ) " Onychomycosis-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Onychomycosis. The Report covers the product profiles in various stages of development including Discovery, Pre-clinical,...
Source: EmailWire.com
 (Medical-NewsWire.com, September 04, 2017 ) Report, "Von Willebrand Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective...
Source: EmailWire.com
 (Medical-NewsWire.com, September 04, 2017 ) " HIV-2 Infection-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the HIV-2 Infection. The Report covers the product profiles in various stages of development including Discovery,...
Source: EmailWire.com
 (Medical-NewsWire.com, September 04, 2017 ) "Thromboxane Synthase Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Thromboxane Synthase Inhibitors. The Report covers the product profiles in various stages of...
Source: EmailWire.com
 (Medical-NewsWire.com, September 04, 2017 ) Report, "Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of...
Source: EmailWire.com
 (Medical-NewsWire.com, September 04, 2017 ) " Cognitive Impairment Associated With Schizophrenia (CIAS)-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Cognitive Impairment Associated With Schizophrenia (CIAS). The Report...
Source: EmailWire.com
|
|
|
|
